Amelioration of osteoarthritis by intra-articular hyaluronan synthase 2 gene therapy

Medical Hypotheses

Volumn 69, Issue 5, 2007, Pages 1111-1113

  Zhang, Da Wei ^a   Yang, Quan Sheng ^a   Zhu, Jin Yu ^a   Cao, Xiao Rui ^a   Li, Li Wen ^a,b   Zhu, Qing Sheng ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b NORTHWEST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CYCLOOXYGENASE 2 INHIBITOR; GLUCURONOSYLTRANSFERASE; HYALURONAN SYNTHASE 2; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG;

ACUTE DISEASE; ARTHROPLASTY; ARTICLE; CARTILAGE DEGENERATION; CLINICAL FEATURE; DRUG EFFICACY; DRUG SYNTHESIS; GENE TARGETING; GENE THERAPY; GENE VECTOR; HUMAN; JOINT EFFUSION; JOINT FUNCTION; OSTEOARTHRITIS; PRIORITY JOURNAL; QUALITY OF LIFE; SEPSIS; UNSPECIFIED SIDE EFFECT;

DNA; GENE TARGETING; GENE THERAPY; GLUCURONOSYLTRANSFERASE; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; OSTEOARTHRITIS;

EID: 34548778598     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.01.084     Document Type: Article

References (25)

1. Vanhoof J., Declerck K., and Geusens P. Prevalence of rheumatic diseases in a rheumatological outpatient practice. Ann Rheum Dis 61 5 (2002) 453-455
2. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000;43(9):1905-15.
3. Grainger R., and Cicuttini F.M. Medical management of osteoarthritis of the knee and hip joints. Med J Aust 180 5 (2004) 232-236
4. Smalley W.E., and Griffin M.R. The risks and costs of upper gastrointestinal disease attributable to NSAIDs. Gastroenterol Clin North Am 25 2 (1996) 373-396
5. Avorn J. Evaluating drug effects in the post-Vioxx world: there must be a better way. Circulation 113 18 (2006) 2173-2176
6. Philipson L.H., and Schwartz N.B. Subcellular localization of hyaluronate synthetase in oligodendroglioma cells. J Biol Chem 259 8 (1984) 5017-5023
7. Knudson C.B., and Knudson W. Hyaluronan-binding proteins in development, tissue homeostasis, and disease. Faseb J 7 13 (1993) 1233-1241
8. Rilla K., Lammi M.J., Sironen R., Torronen K., Luukkonen M., Hascall V.C., et al. Changed lamellipodial extension, adhesion plaques and migration in epidermal keratinocytes containing constitutively expressed sense and antisense hyaluronan synthase 2 (Has2) genes. J Cell Sci 115 Pt 18 (2002) 3633-3643
9. Itano N., Atsumi F., Sawai T., Yamada Y., Miyaishi O., Senga T., et al. Abnormal accumulation of hyaluronan matrix diminishes contact inhibition of cell growth and promotes cell migration. Proc Natl Acad Sci USA 99 6 (2002) 3609-3614
10. Laurent T.C., Laurent U.B., and Fraser J.R. The structure and function of hyaluronan: an overview. Immunol Cell Biol 74 2 (1996) A1-A7
11. Yasui T., Akatsuka M., Tobetto K., Hayaishi M., and Ando T. The effect of hyaluronan on interleukin-1 alpha-induced prostaglandin E2 production in human osteoarthritic synovial cells. Agents Actions 37 1-2 (1992) 155-156
12. Akatsuka M., Yamamoto Y., Tobetto K., Yasui T., and Ando T. In vitro effects of hyaluronan on prostaglandin E2 induction by interleukin-1 in rabbit articular chondrocytes. Agents Actions 38 1-2 (1993) 122-125
13. Wang C.T., Lin Y.T., Chiang B.L., Lin Y.H., and Hou S.M. High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis. Osteoarthr Cartilage 14 12 (2006) 1237-1247
14. Homandberg G.A., Hui F., Wen C., Kuettner K.E., and Williams J.M. Hyaluronic acid suppresses fibronectin fragment mediated cartilage chondrolysis: I. In vitro. Osteoarthr Cartilage 5 5 (1997) 309-319
15. Williams J.M., Plaza V., Hui F., Wen C., Kuettner K.E., and Homandberg G.A. Hyaluronic acid suppresses fibronectin fragment mediated cartilage chondrolysis: II. In vivo. Osteoarthr Cartilage 5 4 (1997) 235-240
16. Gotoh S., Onaya J., Abe M., Miyazaki K., Hamai A., Horie K., et al. Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats. Ann Rheum Dis 52 11 (1993) 817-822
17. Pozo M.A., Balazs E.A., and Belmonte C. Reduction of sensory responses to passive movements of inflamed knee joints by hylan, a hyaluronan derivative. Exp Brain Res 116 1 (1997) 3-9
18. Maneiro E., de Andres M.C., Fernandez-Sueiro J.L., Galdo F., and Blanco F.J. The biological action of hyaluronan on human osteoartritic articular chondrocytes: the importance of molecular weight. Clin Exp Rheumatol 22 3 (2004) 307-312
19. Tamir E., Robinson D., Koren R., Agar G., and Halperin N. Intra-articular hyaluronan injections for the treatment of osteoarthritis of the knee: a randomized, double blind, placebo controlled study. Clin Exp Rheumatol 19 3 (2001) 265-270
20. Lohmander L.S., Dalen N., Englund G., Hamalainen M., Jensen E.M., Karlsson K., et al. Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Hyaluronan multicentre trial group. Ann Rheum Dis 55 7 (1996) 424-431
21. Weigel P.H., Hascall V.C., and Tammi M. Hyaluronan synthases. J Biol Chem 272 22 (1997) 13997-14000
22. Itano N., and Kimata K. Expression cloning and molecular characterization of HAS protein, a eukaryotic hyaluronan synthase. J Biol Chem 271 17 (1996) 9875-9878
23. Shyjan A.M., Heldin P., Butcher E.C., Yoshino T., and Briskin M.J. Functional cloning of the cDNA for a human hyaluronan synthase. J Biol Chem 271 38 (1996) 23395-23399
24. Itano N., Sawai T., Yoshida M., Lenas P., Yamada Y., Imagawa M., et al. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 274 35 (1999) 25085-25092
25. Stern R., Asari A.A., and Sugahara K.N. Hyaluronan fragments: an information-rich system. Eur J Cell Biol 85 8 (2006) 699-715